Moreover, patients with prostate cancer showed higher levels of LOY in granulocytes and CD4 + T lymphocytes, suggesting that these cells, when affected by LOY, might convey an increased risk of cancer, and this finding motivated the current study9. This evidence concerns the gene CD4 and prostate cancer.